L’Oreal Joins $38.6 Million Funding Round For Biotech Start-up Abolis



IDCDENFGPVACVBTDKAGEY3OXIM

L’Oreal has joined Abolis Biotechnologies’s €35 million ($38.6 million) funding round alongside speciality chemicals group Evonik, as part of a deal to develop bio-based ingredients for beauty products, the French cosmetics group said on Thursday.

Located in the Genopole – a biotechnology research hub in Evry, south of Paris – Abolis is a French start-up specialised in the use of micro-organisms. Since its funding in 2014, it has raised 1.1 million euros.

Learn more:

L’Oréal Bets on Longevity Biotech Company Timeline

On Tuesday, L’Oréal Groupe’s venture capital arm, BOLD (Business Opportunities for L’Oréal Development), announced an investment in Swiss consumer health company Timeline.



Source link

About The Author

Scroll to Top